National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 3,619 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died

Government Disclaimer on use of this data



Case Details (Sorted by Age)

This is page 25 out of 362

Result pages: prev   16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next


VAERS ID: 1152980 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-23
Onset:2021-03-04
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210304; Test Name: positive after 9 days; Test Result: Positive
CDC Split Type: NLPFIZER INC2021333751

Write-up: vaccination failure/COVID-19 confirmed by positive COVID-19 test 9 days after start; COVID-19 confirmed by positive COVID-19 test 9 days after start; This is a spontaneous report from a contactable physician downloaded from the Agency Agency-WEB, regulatory authority number NL-LRB-00482557. An 87-year-old female patient received the first dose of bnt162b2 (COMIRNATY), on 26Jan2021 and then received the second dose on 23Feb2021 both via an unspecified route of administration as a single dose for COVID-19 vaccination. The patient''s medical history and concomitant medications were not reported. On 04Mar2021, the patient experienced vaccination failure/covid-19 confirmed by positive covid-19 test 9 days after start. The outcome of the events was fatal. Cause of death was vaccination failure/covid-19 confirmed by positive covid-19 test 9 days after start. The patient died on an unspecified date. It was unknown if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: COVID-19 confirmed by positive COVID-19 test 9 days after start; vaccination failure/COVID-19 confirmed by positive COVID-19 test 9 days after start


VAERS ID: 1153708 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-19
Onset:2021-02-01
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Chest X-ray, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-13
   Days after onset: 12
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Dementia (advanced)
Preexisting Conditions: Comments: Unsure if patient has had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Name: Chest X-ray; Result Unstructured Data: Test Result:unremarkable; Test Date: 20210201; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021327159

Write-up: SARS-CoV-2 infection/ Vaccine breakthrough infection; This is a spontaneous report from a contactable healthcare professional. This is a report received from the regulatory authority. Regulatory authority report number GB-MHRA-WEBCOVID-202103231343284950, Safety Report Unique Identifier GB-MHRA-ADR 25005895. An 82-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at a single dose for COVID-19 immunisation. Medical history included ongoing dementia (advanced). Unsure if patient has had symptoms associated with COVID-19. She was not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient experienced SARS-CoV-2 infection and vaccine breakthrough infection on 01Feb2021. The events were assessed as serious by HA (fatal and medically significant). Case narrative: The patient received COVID vaccination 19Jan2021, confirmed COVID positive 01Feb2021. Treated with antibiotics. Chest x-ray unremarkable. Died 13Feb2021. Cause of death 1) advanced dementia and 2) COVID-19. An autopsy was not performed. The patient underwent lab tests and procedures which included COVID-19 virus test: yes - positive COVID-19 test on 01Feb2021. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Dementia; SARS-CoV-2 infection/ Vaccine breakthrough infection


VAERS ID: 1153726 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Cardiac arrest, Coronavirus test, Drug ineffective, Dyspnoea
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Lack of efficacy/effect (narrow), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Respiratory failure (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac failure congestive; Cardiac pacemaker insertion; Lipids NOS
Allergies:
Diagnostic Lab Data: Test Name: Coronavirus test; Result Unstructured Data: Test Result:found positive for Corona
CDC Split Type: ILPFIZER INC2021330257

Write-up: Cardiac arrest and breathing; Cardiac arrest and breathing; Was found positive for Corona the day prior death; Was found positive for Corona the day prior death; This is a spontaneous report received from a contactable other HCP. A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via unspecified route on unknown date for COVID-19 immunization. Medical history included Cardiac failure congestive, Cardiac pacemaker insertion and Lipid disorder. Concomitant medications were not reported. On unknown date the patient experienced Cardiac arrest and breathing and he was found positive for Corona the day prior death. No follow-up attempts are possible, information about batch /lot number cannot be obtained; Sender''s Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. Cardiac arrest and Breathing difficult are most likely related to an intercurrent or underlying condition which is not related to the suspected drug. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: breathing difficult; Cardiac arrest and breathing


VAERS ID: 1153788 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: MTPFIZER INC2021338126

Write-up: covid-19; covid-19; This is a spontaneous report from a contactable physician through a sales representative. This is the 1st report out of 6 from the same reporter reporting similar events for 6 different patients. An over 80 years old elderly patient of an unspecified gender received first and second dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiration date were not reported) as single dose, for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had died from COVID-19 (despite being fully vaccinated) within 14 days of taking the second dose. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested.; Sender''s Comments: Drug causality cannot be excluded for suspect medication BNT162B2 in onset of the reported events. It was noted that patient had died from COVID-19 (despite being fully vaccinated) within 14 days of taking the second dose. Case will be reassessed upon receipt of additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.; Reported Cause(s) of Death: Drug ineffective; COVID-19


VAERS ID: 1161286 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Condition aggravated
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Suspected COVID-19 (assumes that he became infected with COVID-19)
Allergies:
Diagnostic Lab Data:
CDC Split Type: CZPFIZER INC2021310332

Write-up: later diagnosed with COVID-19/but vaccine could have worsened his condition significantly; Deterioration of the condition/but vaccine could have worsened his condition significantly; This is a spontaneous report from a contactable consumer downloaded from the Agency Regulatory Authority- CZ-CZSUKL-21002669. An adult male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Lot Number: Unknown) as single dose for COVID-19 immunisation. Medical history included COVID-19, assumes that he became infected with COVID-19 just before the vaccination. The patient''s concomitant medications were not reported. The patient experienced the first symptoms of infection after the vaccination. In the first days of the infection, the patient attributed his condition to adverse reactions after the vaccination. He was later diagnosed with COVID-19 on an unspecified date. The reporter has impression that was a coincidence of two events, but vaccine could have worsened the condition/ deterioration of the condition of the patient significantly. The patient died 1 week after the vaccination with COMIRNATY on an unspecified date due to the events. It was not reported if an autopsy was performed. Information on the batch/lot number has been requested.; Reported Cause(s) of Death: later diagnosed with COVID-19/but vaccine could have worsened his condition significantly; Deterioration of the condition/but vaccine could have worsened his condition significantly


VAERS ID: 1161353 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-01
Onset:2021-03-01
   Days after vaccination:28
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9788 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Culture urine, SARS-CoV-2 test, Urinary tract infection, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-12
   Days after onset: 11
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Cancer (Discovered at the end of 2018, initially treated with concomitant radiochemotherapy); Palliative care (Due to cancer of the lower rectum)
Preexisting Conditions: Medical History/Concurrent Conditions: Aneurysm; Aortic aneurysm repair (Thoracic aortic aneurysm operated by custom thoracic endoprosthesis); Arrhythmia (Complete arrhythmia due to atrial fibrillation); Atrial fibrillation (Complete arrhythmia due to atrial fibrillation); Benign prostatic hyperplasia; Colocolostomy (Discharge colostomy); Herniated disc; Osteoarthritis; Pleurisy; Thoracic aortic aneurysm (Thoracic aortic aneurysm operated by custom thoracic endoprosthesis)
Allergies:
Diagnostic Lab Data: Test Date: 202103; Test Name: Urine culture; Result Unstructured Data: Test Result:Positive for Citrobacter freundii; Test Date: 202103; Test Name: PCR Covid test; Result Unstructured Data: Test Result:Pos: variant (S gene N501Y, A570D mut); Comments: Positive for the variant (presence of the N501Y and A570D mutations of the S gene)
CDC Split Type: FRPFIZER INC2021311532

Write-up: Vaccination failure; Vaccination failure; Urinary tract infection; This is a spontaneous report from a contactable pharmacist downloaded from the Agency Regulatory Authority-WEB (regulatory authority number: FR-AFSSAPS-CN20210903). An 89-year-old male patient received the first single dose of BNT162b2 (COMIRNATY), via an unspecified route of administration, on 11Jan2021 (Lot Number: EM0477), and the second dose, intramuscular, on 01Feb2021 (Lot Number: EK9788), for COVID-19 immunisation. The patient was vaccinated with a 25G 25 mm needle. The patient''s medical history included cancer of lower rectum discovered at the end of 2018, initially treated with concomitant radiochemotherapy, then discharge colostomy was performed in Dec2019, and finally palliative care from Jul2020, due to which the patient was in a nursing home. Additional medical history included complete arrhythmia due to atrial fibrillation, herniated disc, osteoarthritis, purulent pleurisy, benign prostatic hyperplasis, thoracic aortic aneurysm operated by custom thoracic endoprosthesis, and popliteal aneurysm. The patient had no previous history of COVID-19. On 04Mar2021 the patient was hospitalized following fever and pharyngeal pain. The patient was put in isolation and a PCR Covid test returned positive for the variant (presence of the N501Y and A570D mutations of the S gene). There was a progressive worsening with associated urinary tract infection (ECBU positive for Citrobacter freundii), patient objecting to treatment. The patient eventually died on 12Mar2021 at 7:05 p.m. It was unknown if an autopsy was performed. The reported event was ''vaccination failure'' with fatal outcome. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: COVID-19; Vaccination failure


VAERS ID: 1161379 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-11
Onset:2021-02-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 1 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, C-reactive protein, COVID-19, Chills, Culture urine, Culture urine positive, Death, Drug ineffective, General physical health deterioration, Hyperthermia, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Accidents and injuries (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-16
   Days after onset: 31
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Dementia Alzheimer''s type (severe Alzheimer''s type dementia); Starvation (undernutrition)
Allergies:
Diagnostic Lab Data: Test Date: 20210212; Test Name: body temperature; Result Unstructured Data: Test Result:38 Centigrade; Test Date: 20210212; Test Name: CRP; Result Unstructured Data: Test Result:15; Test Date: 20210212; Test Name: ECBU test (Urine culture); Test Result: Positive ; Test Name: COVID 19; Result Unstructured Data: Test Result:contracted
CDC Split Type: FRPFIZER INC2021333510

Write-up: sars-cov-2 test: contracted (positive); sars-cov-2 test: contracted (positive); Death NOS; deterioration of the general condition as well as a progressive loss of autonomy; (Urine culture) positive; chills; hyperthermia at 38 degree C; This is a spontaneous report from a contactable physician reporting for a patient downloaded from the Regulatory Authority, regulatory authority number FR-AFSSAPS-TO20211826. An 88-year-old female patient received bnt162b2 (COMIRNATY), first dose, intramuscular, administered in Arm Right on 11Feb2021 (Batch/Lot Number: EJ6788) as SINGLE DOSE for covid-19 immunisation. Medical history included dementia alzheimer''s type (severe Alzheimer''s type dementia) and starvation (undernutrition) from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced death nos on 16Mar2021. Clinical course was reported as follows: The patient received the first injection of the COMIRNATY vaccine on 11Feb2021 and presented the following day, i.e. 12Feb2021, with hyperthermia at 38 degree C and chills. She was put on antibiotics, CRP at 15 and ECBU (Urine culture) positive. A deterioration of the general condition as well as a progressive loss of autonomy were reported leading to his death on 16Mar2021, i.e. 33 days after vaccination. The patient underwent lab tests and procedures which included body temperature: 38 centigrade on 12Feb2021, c-reactive protein: 15 on 12Feb2021, sars-cov-2 test: contracted (positive) on an unspecified date, and ECBU test (urine culture): positive on 12Feb2021. The patient died on 16Mar2021 (Death NOS). Outcome of the other events was unknown. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected. Lot number has been obtained.; Reported Cause(s) of Death: death NOS


VAERS ID: 1161667 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-14
Onset:2021-01-26
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Chest X-ray, Polymerase chain reaction, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-31
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Clinical trial participant (RECOVERY, REGN monoclonal antibodies)
Allergies:
Diagnostic Lab Data: Test Name: CXR; Result Unstructured Data: Test Result:Unknown result; Test Name: PCR; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210126; Test Name: COVID-19 virus test; Test Result: Positive ; Comments: Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021333924

Write-up: SARS-CoV-2 infection; This is a spontaneous report from a contactable other hcp received from the Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202103230953268490, Safety Report GB-MHRA-ADR 25004289. A 93-year-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 14Jan2021 (Batch/Lot number was not reported) at a single dose for covid-19 immunisation. Medical history included clinical trial participant from an unknown date and unknown if ongoing (RECOVERY, REGN monoclonal antibodies), It was unsure if patient has had symptoms associated with COVID-19. The patient''s concomitant medications were not reported. The patient experienced sars-cov-2 infection on 26Jan2021. The patient underwent lab tests included Covid-19 virus test: positive on 26Jan2021 (Yes - Positive COVID-19 test), polymerase chain reaction (PCR) and chest x-ray (CXR): unknown results. Therapeutic measures were taken as a result of sars-cov-2 infection. The patient died on 31Jan2021. It was not reported if an autopsy was performed. Additional information: Patient received covid vaccine 14Jan2021, admitted to hospital and tested positive for COVID 26Jan2021. Patient treated with REGN monoclonal antibodies covid vacs as part of RECOVERY trial. Also treated with dexamethasone and antibiotics as part of usual treatment. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: COVID-19


VAERS ID: 1161668 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-07
Onset:2021-01-31
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Chest X-ray, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-08
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Chest X-ray; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210131; Test Name: COVID-19 virus test; Test Result: Positive ; Comments: Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021334014

Write-up: SARS-CoV-2 infection/Vaccine breakthrough infection; SARS-CoV-2 infection/Vaccine breakthrough infection; This is a spontaneous report from a contactable healthcare professional received from the Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202103231247133620, Safety Report Unique Identifier is GB-MHRA-ADR 25005489. An 86-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. It was unsure if patient has had symptoms associated with COVID-19. Patient was not enrolled in clinical trial. On 31Jan2021, the patient experienced SARS-CoV-2 infection/vaccine breakthrough infection. It was reported that the patient received COVID vaccine on 07Jan2021. Tested positive for COVID on 31Jan2021 and was admitted to hospital. Treated with antibiotics and dexamethasone. The reporter assessed the events as serious (hospitalization and death). The patient underwent lab tests and procedures which included chest x-ray: unknown results on an unspecified date and COVID-19 virus test: positive (yes/positive COVID-19 test) on 31Jan2021. The outcome of the events was fatal. The patient died on 08Feb2021 due to SARS-CoV-2 infection/vaccine breakthrough infection. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about batch/lot number cannot be obtained.; Reported Cause(s) of Death: SARS-CoV-2 infection/Vaccine breakthrough infection; SARS-CoV-2 infection/Vaccine breakthrough infection


VAERS ID: 1161850 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: MTPFIZER INC2021343748

Write-up: had died from COVID-19 (despite being fully vaccinated) within 14 days; had died from COVID-19 (despite being fully vaccinated) within 14 days; This is a spontaneous report from a contactable physician via corporation sales representative. This physician reported similar events for 6 patients. This is the second of 6 reports. A 9-decade (over 80 years old) patient of an unspecified gender received BNT162B2 (COMIRNATY, solution for injection), dose 1 and dose 2, both via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiration date were not reported) at single dose, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had died from COVID-19 (despite being fully vaccinated) within 14 days of taking the second dose. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested.; Sender''s Comments: The causal relationship between BNT162B2 and the events drug ineffective and Covid 19 cannot be excluded as the information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : MT-PFIZER INC-2021338126 same reporter, same drug, same events, different patient; Reported Cause(s) of Death: had died from COVID-19 (despite being fully vaccinated) within 14 days; had died from COVID-19 (despite being fully vaccinated) within 14 days


Result pages: prev   16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=25&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166